Thank you, Fred. And good afternoon, everyone. As Fred mentioned, our net sales were $139.4 million in Q3, which is higher than what we achieved in last year's Q3. Of the $139.4 million of net sales, 79.8% were to the U.S. based customers with 20.2% to international customers. Bookings for the third quarter were $115.9 million. And our consolidated book-to-bill ratio was 0.83. We finished the quarter with backlog of $636.5 million. And when you factor in the total unfunded value have certain multiyear contracts that have been awarded to us, but which are not yet in our backlog, we have visibility into approximately $1.1 billion of potential future revenue. Our gross profit percentage in Q3 of fiscal 2021 was 38% as compared to the 39.2%, achieved in the third quarter of 2020. The period-over-period change in our gross profit percentage reflects changes in overall product mix and significant increases in costs due to production delays, minor supply chain disruptions, lower levels of factory utilization, and higher logistics and operational costs resulting from the COVID-19 pandemic. Q3 of fiscal 2021 also reflects a $2 million benefit from the recovery of historical excise tax paid. Based on our expected level and mix of net sales for the remainder of fiscal 2021, we anticipate a consolidated gross margin percentage approximating 36%. SG&A for Q3 of fiscal 2021 was $27 million or 19.4% of consolidated net sales, as compared to $32.3 million, or 23.9% in Q3 of fiscal 2020. In Q3 fiscal 2021, we incurred $600,000 of restructuring costs related to the shifting of production of many of our key satellite earth station products from our existing Tempe, Arizona locations to a new 146,000 square foot facility in Chandler, Arizona. We expect about another $1 million of such costs in Q4. Turning to R&D, we spent $13.1 million in the third quarter, or 9.4% of net sales. Total stock-based compensation for the third quarter was $1.2 million. And amortization of intangibles was $5.3 million. We continue to expect stock-based compensation to approximate $11 million to $12 million for FY 2021. Our consolidated GAAP operating income was $2.4 million, and reflects $5.3 million of acquisition plan expenses, primarily due to the April 2021 settlement of an acquisition related litigation and our completed acquisition of UHP. Our adjusted EBITDA was $17.7 million, or 12.7% of consolidated net sales for the third quarter of fiscal 2021. Adjusted EBITDA in our commercial solution segment was $15.9 million, or 17.4% of related sales. And in our government solution segment, it was $3 million, or 6.3% of related net sales. For fiscal 2021 using the midpoint of our consolidated net sales and adjusted EBITDA targets, our adjusted EBITDA margin approximates 13%.